Search database
Filter
11
Text search: F. Brigden
Featured
Language
Document type
No document type
8
Studies & Reports
2
Training Material
1
Authors & Publishers
END TB
2
Stop TB Partnership
2
UNOPS
2
World Health Organization WHO
2
and J. Roberto
1
Barba, E.
1
College of American Pathologists
1
F. Brigden
1
M. Ya Diul
1
Medecins Sans Frontieres
1
Médecins Sans Frontières (MSF)
1
Organisation Mondiale de la Santé OMS
1
R. H.Crespo, L. Ditiu, A. Kurats, etc al.
1
Stop TB Partnership to reach
1
World Health Organization
1
World Health Organization WHO, Stop TB
1
Publication Years
Category
Clinical Guidelines
2
Public Health
1
Pharmacy & Technologies
1
Toolboxes
TB
10
Natural Hazards
1
HIV
1
Report: A survey conducted among the 27 high MDR-TB burden countries. March – July 2015 Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF). Accessed November 2017.
Improve identification, verification, communication and coordination.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi ... more
A review of available evidence (2016). 28-29 June 2016; Geneva, Switzerland The END TB strategy.
Rev Mex Patol Clin Med Lab 2020; 67 (2): 93-112: La tuberculosis (TB) es en la actualidad la patología de tipo infeccioso que causa mayor número de muertes alrededor del mundo cada año. La percepción acerca de esta entidad ha cambiado a lo largo del tiempo, ya que se consideraba que se relaciona ... more
Interim policy guidance.
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ ... more
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб ... more